Carysil Q1 Results: Net Profit Rises to ₹310M, EBITDA Margin Expands to 20.4%
Carysil Limited reported strong Q1 results with consolidated net profit rising to ₹310M from ₹230M year-on-year, revenue growing to ₹2.6B from ₹2.3B, and EBITDA increasing to ₹534M from ₹438M. The EBITDA margin expanded to 20.4% from 19.3%, reflecting improved operational efficiency. Results were discussed at an earnings call on August 11, 2026, hosted by Go India Advisors, featuring Chairman & MD Chirag Parekh and Group CFO Anand Sharma.

*this image is generated using AI for illustrative purposes only.
Carysil Limited has reported its financial results for the first quarter, posting a consolidated net profit of ₹310M compared to ₹230M in the same period last year, reflecting a robust year-on-year improvement. Revenue for the quarter came in at ₹2.6B versus ₹2.3B in the corresponding period, while EBITDA rose to ₹534M from ₹438M, with the EBITDA margin expanding to 20.4% from 19.3%. The results were discussed during an earnings conference call held on Tuesday, August 11, 2026, at 4:00 PM IST, hosted by Go India Advisors.
Q1 Financial Highlights
Carysil's quarterly performance reflects broad-based improvement across key financial metrics. The following table summarises the year-on-year comparison:
| Metric: | Q1 FY27 | Q1 FY26 (YoY) |
|---|---|---|
| Revenue: | ₹2.6B | ₹2.3B |
| EBITDA: | ₹534M | ₹438M |
| EBITDA Margin: | 20.4% | 19.3% |
| Consolidated Net Profit: | ₹310M | ₹230M |
Earnings Call Details
The earnings conference call featured key leadership from Carysil Limited. Mr. Chirag Parekh, Chairman and Managing Director, and Mr. Anand Sharma, Executive Director and Group CFO, addressed queries from analysts and investors following the presentation of the Q1 results. The call was hosted by Go India Advisors, and the audio recording and transcript are available on the company's website at https://carysil.com/ .
| Participant | Designation |
|---|---|
| Chirag Parekh | Chairman & Managing Director |
| Anand Sharma | Executive Director & Group CFO |
Dial-In Information
The earnings call offered multiple access points for domestic and international participants, with universal dial-in numbers for India and toll-free numbers for the USA, UK, Singapore, and Hong Kong.
| Region | Contact Number |
|---|---|
| India (Universal) | +91 22 6280 1557 / +91 22 7115 8383 |
| USA (Toll Free) | 1866 746 2133 |
| UK (Toll Free) | 0808 1011 573 |
| Singapore (Toll Free) | 800 101 2045 |
| Hong Kong (Toll Free) | 800 964 448 |
Contact Information
For further information or assistance regarding the earnings call, investors may contact the advisors at Go India Advisors:
- Sheetal Khanduja: sheetal@goindiaadvisors.com / +91 9769364166
- Garima Singla: garima@goindiaadvisors.com / +91 9780042377
The original earnings call announcement was signed by Reena Tejas Shah, Company Secretary and Compliance Officer, on August 05, 2026.
Historical Stock Returns for CARYSIL
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +5.73% | +6.50% | +11.93% | +32.06% | +57.66% | +92.94% |
What specific operational strategies or cost-control measures drove the expansion of EBITDA margins from 19.3% to 20.4% in Q1 FY27?
How does management plan to sustain this revenue growth trajectory given the current competitive landscape in the specialty chemicals sector?
Are there any upcoming capital expenditure plans or capacity expansions announced during the call that could impact future cash flows?


































